| Financial Year |
March 31 2023 |
| Monetary Funds |
461,453,796.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,219,366.67 |
| Accounts Receivable |
38,859,195.03 |
| Advances to Suppliers |
6,078,633.41 |
| Other Receivables |
33,270,004.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
1,364,188,790.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
25,928,783.18 |
| Investment Properties |
-- |
| Fixed Assetes |
38,846,507.74 |
| Under-construction Projects |
98,596,508.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,742,773.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,269,045.75 |
| Deferred Income Tax Assets |
58,477,038.98 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
312,628,304.53 |
| Total Assets |
1,676,817,094.56 |
| Short-Term Loans |
13,013,777.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,842,200.00 |
| Accounts Payable |
394,718,403.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
70,451,651.51 |
| Taxes Payable |
69,160,547.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,357,114.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,642,741.57 |
| Other Current Liabilities |
11,168,819.00 |
| Sub-Total of Current Liabilities |
810,280,553.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
65,160.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,398,517.55 |
| Total Liabilities |
819,679,070.65 |
| Paid-In Capital(Or Share Stock) |
171,600,000.00 |
| Capital Surplus |
437,546,756.49 |
| Surplus Reserve |
33,430,250.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
214,561,467.54 |
| Minority Stockholder's Interest |
-450.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
857,138,474.48 |
| Owner's Equity（Stockholder's Equity） |
857,138,023.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,676,817,094.56 |
